HUNTER LAMPLEY: Open Payments
NPI 1033783774 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 140 payments from 22 companies in 2025. Trend: 2023 $2,253 · 2024 $2,424 · 2025 $3,062
Food & beverage: $3,062
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $844 |
| Madrigal Pharmaceuticals | 9 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $270 |
| Janssen Biotech, Inc. | 11 | $250 |
| Lilly USA, LLC | 9 | $201 |
| GENZYME CORPORATION | 7 | $152 |
| Ardelyx, Inc. | 7 | $142 |
| Gilead Sciences, Inc. | 7 | $139 |
| Celltrion USA Inc. | 6 | $120 |
| QOL Medical, LLC | 4 | $104 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, OMVOH, DUPIXENT, ENTYVIO, CREON, SKYRIZI.
Industry payments across TN — which companies pay providers there.
